An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...

書誌詳細
主要な著者:	André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V
フォーマット:	Journal article
言語:	English
出版事項:	1998

類似資料

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
著者:: Cerundolo, V, 等
出版事項: (1998)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
著者:: Kelleher, A, 等
出版事項: (2001)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
著者:: Gileadi, U, 等
出版事項: (1999)

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
著者:: Klenerman, P, 等
出版事項: (1998)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
著者:: Anjali K. Gupta, 等
出版事項: (2007-04-01)

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
著者:: Milicic, A, 等
出版事項: (2005)

Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
著者:: Atul Pawar, 等
出版事項: (2020-01-01)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
著者:: Valmori, D, 等
出版事項: (1999)

Computational investigations of HIV-1 protease and protease inhibitors interactions
著者:: Sham, Hoi Fung
出版事項: (2014)

The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
著者:: Cerundolo, V, 等
出版事項: (1997)

Current and Novel Inhibitors of HIV Protease
著者:: Jan Konvalinka, 等
出版事項: (2009-12-01)

Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
著者:: Johanna Bialas, 等
出版事項: (2015-01-01)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
著者:: Kourjian G, 等
出版事項: (2012-09-01)

Additivity in the Analysis and Design of HIV Protease Inhibitors
著者:: Jorissen, Robert N., 等
出版事項: (2012)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
著者:: V.B. Denisenko, 等
出版事項: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
著者:: V.B. Denisenko, 等
出版事項: (2010-02-01)

Proteasome inhibitors as anti-cancer agents.
著者:: Murray, R, 等
出版事項: (2000)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
著者:: Valmori, D, 等
出版事項: (1999)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
著者:: Gupta, A, 等
出版事項: (2005)

Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
著者:: Larissa da Costa Souza, 等
出版事項: (2014-01-01)

New proteasome inhibitors in the management of multiple myeloma
著者:: S. V. Semochkin
出版事項: (2019-07-01)

MAPPING OF PATENTS RELATED TO PROTEASE INHIBITORS AND HIV
著者:: Romério Rodrigues dos Santos Silva, 等
出版事項: (2022-04-01)

Role of Gag in HIV Resistance to Protease Inhibitors
著者:: Fabrizio Mammano, 等
出版事項: (2010-07-01)

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
著者:: Roberta Rinaldi, 等
出版事項: (2021-11-01)

TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
著者:: Abhilash I. Chiramel, 等
出版事項: (2019-06-01)

Site-Specific Proteasome Inhibitors
著者:: Alexei F. Kisselev
出版事項: (2021-12-01)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
著者:: Noah M. Merin, 等
出版事項: (2014-12-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
著者:: Christoph Driessen, 等
出版事項: (2016-03-01)

Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.
著者:: Hemelaar, J, 等
出版事項: (2001)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
著者:: Nathalie Vigneron, 等
出版事項: (2015-09-01)

Evaluation of COVID-19 protease and HIV inhibitors interactions
著者:: Tran Linh, 等
出版事項: (2022-03-01)

Safety of protease inhibitors in HIV-infected pregnant women
著者:: Chougrani I, 等
出版事項: (2013-09-01)

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
著者:: Kathleen M S E Reyskens, 等
出版事項: (2013-01-01)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
著者:: Konvalinka Jan, 等
出版事項: (2011-08-01)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
著者:: Kann G, 等
出版事項: (2021-08-01)

Immune surveillance and AIDS progression.
著者:: Zinkernagel, R, 等
出版事項: (1997)

Correspondence - Immune surveillance and AIDS progression
著者:: Zinkernagel, R, 等
出版事項: (1997)

Of mice and men: cytotoxic T cells and AIDS pathogenesis.
著者:: Klenerman, P, 等
出版事項: (1999)

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
著者:: Klenerman, P, 等
出版事項: (1997)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
著者:: J. Lopes, 等
出版事項: (2021-04-01)